Technology

AddToAny

Google+ Facebook Twitter Twitter

New serology assays

Vircell has added a number of new assays to its VirClia range, enhancing the extensive portfolio of chemiluminescent monotests for infectious disease serology.

Cila Vircell

New assays include Hepatitis E IgG and IgM, Toxoplasma IgG AVIDITY, Cytomegalovirus IgG AVIDITY, Tick Borne Encephalitis IgG and IgM and Chikungunya IgG and IgM. The VirClia system offers a comprehensive solution for the automation of infectious serology.

launchdiagnostics.com

Related Articles

The new dawn of immunotherapy

Steven Rosenberg made headlines around the globe for a breakthrough that could make immunotherapy a frontline cancer treatment.

Vaccine to treat lung cancer

A first-of-its-kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.

Journal-based learning: iStock

July: Journal-based learning

Each article’s contents should be read, researched and understood, and you should then come to a decision on each question. The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date. Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

Could bacteriophages replace antibiotics?

A small-scale preliminary trial concludes that bacteriophages could be a viable replacement for antibiotics in the future.

Top